Showing 1921-1930 of 2652 results for "".
- Complexity Gaming Kicks Off Year-Long Partnership With Alconhttps://modernod.com/news/complexity-gaming-kicks-off-year-long-partnership-with-alcon/2479475/Esports company Complexity Gaming announced a partnership with Alcon. The partnership will designate Alcon’s signature brand of lubricant eye drops, Systane, as the first official eye care partner of Complexity Gaming. Now more than ever, dry eye symptoms are affecting people due to increa
- Sight Sciences Announces Publication of 2-Year Outcomes of Standalone Use of the OMNI Surgical Systemhttps://modernod.com/news/sight-sciences-announces-publication-of-two-year-outcomes-of-standalone-use-of-the-omni-surgical-system-in-mild-to-moderate-open-angle-glaucoma/2479466/Sight Sciences announced publication in
- Modernizing Medicine Showcases Single-Screen Innovations at ASCRShttps://modernod.com/news/modernizing-medicine-showcases-single-screen-innovations-at-ascrs/2479405/Modernizing Medicine announced it has enhanced its electronic health records (EHR), EMA with functionality that can help to speed up documentation by removing steps in note-taking and allowing for quick editing, importing charts and more. These new and improved workflows for clinical docu
- “Love Your Eyes” Theme of 2021 World Sight Dayhttps://modernod.com/news/love-your-eyes-theme-of-2021-world-sight-day/2479345/The International Agency for the Prevention of Blindness (IAPB) and its members are calling on everyone to focus on their eye health in a global campaign – #LoveYourEyes. The theme and materials are being launched on July 6 to mark 100 days to go until World Sight Day on October 14.
- Nanoscope’s Optogenetic Gene Therapy Restores Clinically Meaningful Vision in 11 Patients Blinded by Retinitis Pigmentosahttps://modernod.com/news/nanoscopes-optogenetic-gene-therapy-restores-clinically-meaningful-vision-in-11-patients-blinded-by-retinitis-pigmentosa/2479261/Nanoscope Therapeutics announced that vision improvements for all evaluated advanced retinitis pigmentosa (RP) patients persisted through 1 year following a single intravitreal injection in a phase 1/2a clinical study with MCO. “We expect to begin the first randomized, placebo-contro
- GenSight Biologics Provides 2021 Operations Update in the Context of COVID-19https://modernod.com/news/gensight-biologics-provides-2021-operations-update-in-the-context-of-covid-19/2479212/GenSight Biologics provided an update on the impact of COVID-19 on its operations in 2021. “It has been slightly over a year since we had to adjust our operations to the COVID-19 situation and provided you with an update on our activities. Although conditions have improved in many regions,
- Essilor to Present New Results for its Stellest Lens for Children With Myopiahttps://modernod.com/news/essilor-to-present-new-results-for-its-stellest-lens-for-children-with-myopia/2479062/Essilor will unveil pivotal 2-year clinical trial results of its Stellest lens for myopia. The 2-year results demonstrate that Essilor Stellest lenses slow down myopia progression by 67% on average, when compared to single vision lenses, when worn at least 12 hours a day,1 according to
- NIH-Sponsored Trial Finds Eylea Reduced Vision-Threatening Complications by 68% After 2 Years in DR Patientshttps://modernod.com/news/nih-sponsored-trial-finds-eylea-reduced-vision-threatening-complications-by-68-after-2-years-in-diabetic-retinopathy-patients/2479034/Regeneron Pharmaceuticals announced that JAMA Ophthalmology has
- Nursing Homes See 96 Percent Decline In COVID Cases Since Vaccine Rollouthttps://modernod.com/news/nursing-homes-see-96-percent-decline-in-covid-cases-since-vaccine-rollout/2479027/The American Health Care Association and National Center for Assisted Living (AHCA/NCAL), which represents more than 14,000 nursing homes and long term care facilities across the US, released a
- J&J’s Coronavirus Vaccine Garners WHO Emergency-Use Listinghttps://modernod.com/news/jjs-coronavirus-vaccine-garners-who-emergency-use-listing/2478968/Johnson & Johnson said that the World Health Organization (WHO) has issued an emergency-use listing for its single-dose coronavirus vaccine Ad26.COV2.S to prevent COVID-19 in people 18 years and older. Chief scientific officer Paul Stoffels stated that “achieving this important prerequi